| Rap1 regulates the formation of E-cadherin-based cell-cell contacts C Hogan, N Serpente, P Cogram, CR Hosking, CU Bialucha, SM Feller, ... Molecular and cellular biology 24 (15), 6690-6700, 2004 | 319 | 2004 |
| Dementia in Latin America: assessing the present and envisioning the future MA Parra, S Baez, R Allegri, R Nitrini, F Lopera, A Slachevsky, N Custodio, ... Neurology 90 (5), 222-231, 2018 | 213 | 2018 |
| Sonic hedgehog and the molecular regulation of mouse neural tube closure P Ybot-Gonzalez, P Cogram, D Gerrelli, AJ Copp Oxford University Press for The Company of Biologists Limited 129 (10), 2507 …, 2002 | 206 | 2002 |
| Dementia in Latin America: paving the way toward a regional action plan MA Parra, S Baez, L Sedeño, C Gonzalez Campo, H Santamaría‐García, ... Alzheimer's & Dementia 17 (2), 295-313, 2021 | 88 | 2021 |
| D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects P Cogram, S Tesh, J Tesh, A Wade, G Allan, NDE Greene, AJ Copp Human Reproduction 17 (9), 2451-2458, 2002 | 83 | 2002 |
| NNZ-2566, a novel analog of (1–3) IGF-1, as a potential therapeutic agent for fragile X syndrome RMJ Deacon, L Glass, M Snape, MJ Hurley, FJ Altimiras, RR Biekofsky, ... Neuromolecular medicine 17, 71-82, 2015 | 79 | 2015 |
| Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol P Cogram, A Hynes, LPE Dunlevy, NDE Greene, AJ Copp Human molecular genetics 13 (1), 7-14, 2004 | 71 | 2004 |
| Neurulation and neural tube closure defects A Copp, P Cogram, A Fleming, D Gerrelli, D Henderson, A Hynes, ... Developmental Biology Protocols: Volume II, 135-160, 2000 | 56 | 2000 |
| Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D) ME Gurney, P Cogram, RM Deacon, C Rex, M Tranfaglia Scientific reports 7 (1), 14653, 2017 | 55 | 2017 |
| Repurposing available drugs for neurodevelopmental disorders: the fragile X experience MR Tranfaglia, C Thibodeaux, DJ Mason, D Brown, I Roberts, R Smith, ... Neuropharmacology 147, 74-86, 2019 | 38 | 2019 |
| Gaboxadol normalizes behavioral abnormalities in a mouse model of fragile X syndrome P Cogram, RMJ Deacon, JL Warner-Schmidt, MJ Von Schimmelmann, ... Frontiers in Behavioral Neuroscience 13, 141, 2019 | 35 | 2019 |
| CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease B Ferraz-de-Souza, F Martin, D Mallet, RE Hudson-Davies, P Cogram, ... The Journal of Clinical Endocrinology & Metabolism 94 (2), 678-683, 2009 | 35 | 2009 |
| The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases MJ Hurley, RMJ Deacon, K Beyer, E Ioannou, A Ibáñez, JL Teeling, ... Pharmacology & therapeutics 188, 36-44, 2018 | 31 | 2018 |
| Natural AD-Like neuropathology in Octodon degus: impaired burrowing and neuroinflammation R MJ Deacon, F J Altimiras, E A Bazan-Leon, R D Pyarasani, ... Current Alzheimer Research 12 (4), 314-322, 2015 | 31 | 2015 |
| Distribution of AGG interruption patterns within nine world populations CM Yrigollen, S Sweha, B Durbin-Johnson, L Zhou, E Berry-Kravis, ... Intractable & rare diseases research 3 (4), 153-161, 2014 | 27 | 2014 |
| Altered gut microbiota in a fragile X syndrome mouse model F Altimiras, JA Garcia, I Palacios-García, MJ Hurley, R Deacon, ... Frontiers in Neuroscience 15, 653120, 2021 | 18 | 2021 |
| Brain transcriptome sequencing of a natural model of Alzheimer's disease F Altimiras, B Uszczynska-Ratajczak, F Camara, A Vlasova, E Palumbo, ... Frontiers in Aging Neuroscience 9, 64, 2017 | 14 | 2017 |
| Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice P Cogram, DL Alkon, D Crockford, RMJ Deacon, MJ Hurley, F Altimiras, ... Scientific Reports 10 (1), 18058, 2020 | 12 | 2020 |
| Human and animal models for translational research on neurodegeneration: challenges and opportunities from South America A Ibáñez, L Sedeño, AM García, RMJ Deacon, P Cogram Frontiers in Aging Neuroscience 10, 95, 2018 | 12 | 2018 |
| Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy ST Reyes, RMJ Deacon, SG Guo, FJ Altimiras, JB Castillo, ... Scientific Reports 11 (1), 17150, 2021 | 11 | 2021 |
